Collectively, our study underlies AHSA1 as a novel target on mediating cellular proliferation and PI resistance in MM, and demonstrates that specific AHSH1 inhibitors have promising prospects in MM treatment. This evidence concerns the gene AHSA1 and Miyoshi myopathy.